Anja Schiel und Norwegian Medicines Agency - Info zur Person

(1 - 37 von 41

)

374: Around the World: Regulator Perspe...dia2022globalannualmeeting.sched.com › vWPY

dia2022globalannualmeeting.sched.com

Anja Schiel, PhD ... Anja Schiel. Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA, Norwegian Medicines Agency (NoMA), Norway. Anja ...

Life Science Summit | April PHASTAR

phastar.com

... Stephen Senn (Statistical Consultant), Frank Harrell (Vanderbilt University), Anja Schiel (Norwegian Medicines Agency), and Eileen Hoffman (Takeda). › ... › Events

EU-HTA-WorkshopDGRA e.V.

www.dgra.de

— Dr. Anja Schiel, Norwegian Medicines Agency, Oslo (virtuelle. Teilnahme). • Dr. Regina Skavron, Gemeinsamer Bundesausschuss (G-BA), Berlin ...

[PDF] 6th EFSPI Regulatory Statistics Workshop 13th – 15th September ...www.efspi.org › Documents › Events

www.efspi.org

Anja Schiel (Norwegian Medicines Agency and EMA BSWP & SAWP). DCT, the new kid on the block. Here to stay? Panel discussion with all speakers.

LinkedIn: Anja Schiel | Berufsprofil - LinkedIn

Sehen Sie sich das Profil von Anja Schiel auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. Zu Anja Schiels Berufserfahrung zählt: Biostatistics Working Party, Norwegian Medicines Agency und University of Oslo. Anja Schiel hat folgende Hochschule besucht: Vrije Universiteit Amsterdam (VU Amsterdam).

Anja Schiel - Alternate Member, Scientific Advice Working ...Apollo.io

www.apollo.io

View Anja Schiel's business profile as Alternate Member, Scientific Advice Working Party at Norwegian Medicines Agency. Find Anja's email address, ...

Loop | Anja Schiel - Loop (Frontiers)loop.frontiersin.org › people › network

loop.frontiersin.org

Anja Schiel. Senior Researcher. The Norwegian Medicines Agency. Oslo, Norway. View All. mini profile avatar Anja Schiel. Overview ...

Universitätsklinikum Heidelberg: AktuellesUniversitätsklinikum Heidelberg

www.klinikum.uni-heidelberg.de

Anja Schiel (Norwegian Medicines Agency, Oslo), welche die Nutzung von Real World Data aus regulatorischer und HTA-Sicht darstellten. Es folgten Vorträge von Dr ...

RWD-Symposium Universitätsklinikum Heidelberg

www.klinikum.uni-heidelberg.de

Anja Schiel (Norwegian Medicines Agency), Dr. Christoph Gerlinger (Bayer AG), Dr. Heiko Götte (Merck Healthcare KGaA), Dr. Dominic Edelmann (Deutsches ... › symposium-2...

DIA Europe Program Commitee - Drug Information Associationwww.diaglobal.org › flagship › about › committee

www.diaglobal.org

Anja Schiel, PhD • Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA. Norwegian Medicines Agency (NoMA), Norway.

DIA Europe Speakers from National Authoritieswww.diaglobal.org › program › schedule › meet-us

www.diaglobal.org

Anja Schiel, Senior Advisor and Statistician, Norwegian Medicines Agency, Norway Anja Schiel is working as Senior Advisor and Statistician for Norwegian ...

DIA Europe National Authorities

www.diahome.org

Anja Schiel is working as Senior Advisor and Statistician for Norwegian Medicines Agency (NoMA). She has studied Biology at the Johannes ... › meet-us

Emerging trends and technologies: a horizon scan for global ...google.com

books.google.com

... Anja Schiel, Norwegian Medicines Agency, Oslo, Norway Petra Verhoef, Rathenau Instituut, The Hague, Netherlands The horizon scan was conducted by a global ...

Emerging trends and technologies: a horizon scan for global ...google.ch

books.google.ch

... Cambridge University, Cambridge, United Kingdom Anja Schiel, Norwegian Medicines Agency, Oslo, Norway Petra Verhoef, Rathenau Instituut, The Hague, ...

Estimands and Complex Innovative Designs - Collignon

ascpt.onlinelibrary.wiley.com

von O Collignon — Anja Schiel. Norwegian Medicines Agency, Oslo, Norway. Search for more papers by this author · Carl-Fredrik Burman,. Carl-Fredrik Burman. › ...

Estimand Framework and Its Impact on Drug Development in ...

oncoestimand.github.io

Anja Schiel. Norwegian Medicines Agency and Chair, EMA Scientific Advice Working Party. • Anja Schiel has studied Biology at the Johannes ... › docs › talks

Towards a better use of scientific advice for developers of advanced ...bpspubs.onlinelibrary.wiley.com › doi › abs › bcp

bpspubs.onlinelibrary.wiley.com

· ... Anja Schiel,. Anja Schiel. Regulatory and Pharmacoeconomic Statistics, Norwegian Medicines Agency (NoMA), Norway. Chair of Scientific Advice ...

[PDF] enhancing-patient-centric-outcome-measures-and-clinical-trials-with ...www.efpia.eu › media › enhancing-patient-centric-outcome-measures...

www.efpia.eu

Anja Schiel (Norwegian Medicines Agency, European Medicines Agency). Cecile Ollivier (Critical-Path Institute). Dimitrios Athanasiou (Eurordis). Elke Stahl ...

Meeting Minutescioms.ch › wp-content › uploads ›

cioms.ch

... Anja Schiel (Norwegian Medicines Agency), David. Shaw (University of Bern, Switzerland), David Wormser (Novartis), and Kristina Zint (Boehringer. Ingelheim) ...

Meeting Minutes

cioms.ch

Medical Association), Anja Schiel (Norwegian Medicines Agency), and Julia Stingl (University of. Aachen, Germany). *New members since previous meeting. (CIOMS), Anja Schiel (Norwegian Medicines Agency), David Shaw (University of Bern, Switzerland),. Julia Wicherski (Bundesinstitut für Arzneimittel und ... › wp-content › uploads ›

[PDF] Meeting Minutescioms.ch › wp-content › uploads ›

cioms.ch

(CIOMS), Anja Schiel (Norwegian Medicines Agency), David Shaw (University of Bern, Switzerland),. David Townend (University of London, UK), Rika Wakao ...

Twitter-Nachrichten: Elizabeth Merrall on X: "Anja Schiel from the Norwegian Medicines ...twitter.com › ElmStatistics › status

· Anja Schiel from the Norwegian Medicines Agency and always an engaging speaker with her thoughts on the "new kid on the block". (8/8)

Twitter-Nachrichten: The Evidence Base on X: "Day 2 of #ISPOREurope is underway ...twitter.com › TheEviBase › status

· ... moderated by Anja Schiel of Norwegian Medicines Agency with @gloriagheq @NeilGrubert Denis Lacombe @EORTC @Ynatsis @ESIP_EU and Johan Pontén.

Anja E. Schiel, PhD, Senior Advisor - RAPS Convergence 2022eventscribe.net

www.eventscribe.net

Anja Schiel (PhD, Lead Methodologist in Regulatory and Pharmacoeconomic Statistics, Norwegian Medicines Agency) has studied Biology at the Johannes ...

Advisory Group | ROADMAPROADMAP Alzheimer

www.roadmap-alzheimer.org

Anja Schiel is working as Senior Advisor and Statistician for Norwegian Medicines Agency (NoMA), which is the Norwegian HTA and regulatory agency, ...

Agenda Day 2 | International Conference on Rare Diseases

www.rarediseases-conference.com

Moderator: Anja SCHIEL, Chair, Scientific Advice Working Party, EMA, Vice Chair EUnetHTA21, Senior Advisor Norwegian Medicines Agency (NoMA). › ...

Governance - Aladdinaladdin-education.eu › governance

aladdin-education.eu

Anja Schiel, PhD. Norwegian Medicines Agency (NoMA), EUnetHTA 21 Vice-Chair. COORDINATED BY. accelerate. LINKS. Home · Contacts · Privacy Policy ...

Schielradgestalten.de

radgestalten.de

En su corta pero agitada vida produjo 340 â€¦Anja Schiel, Department of Health Economy, Norwegian Medicines Agency, Grensesvingen 26, Oslo, Norway.

Making Real World Data Real – New RWE Methodologies for HTAsvitaltransformation.com › › making-real-world-data-real-new-rwe...

vitaltransformation.com

Anja Schiel, PhD. Lead Methodologist in Regulatory and Pharmacoeconomic Statistics Norwegian Medicines Agency (NoMA). Duane Schulthess Managing Director Vital ...

Joey Zhou
Katja Stolz

Person "Schiel" (5)
Vorname "Anja" (46996)
Name "Schiel" (558)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Anja Schiel und Norwegian Medicines Agency Person-Info

374: Around the World: Regulator Perspe...dia2022globalannualmeeting.sched.com › vWPY

Life Science Summit | April PHASTAR

EU-HTA-WorkshopDGRA e.V.

[PDF] 6th EFSPI Regulatory Statistics Workshop 13th – 15th September ...www.efspi.org › Documents › Events

LinkedIn: Anja Schiel | Berufsprofil - LinkedIn

Anja Schiel - Alternate Member, Scientific Advice Working ...Apollo.io

Loop | Anja Schiel - Loop (Frontiers)loop.frontiersin.org › people › network

Universitätsklinikum Heidelberg: AktuellesUniversitätsklinikum Heidelberg

RWD-Symposium Universitätsklinikum Heidelberg

DIA Europe Program Commitee - Drug Information Associationwww.diaglobal.org › flagship › about › committee

DIA Europe Speakers from National Authoritieswww.diaglobal.org › program › schedule › meet-us

DIA Europe National Authorities

Emerging trends and technologies: a horizon scan for global ...google.com

Emerging trends and technologies: a horizon scan for global ...google.ch

Estimands and Complex Innovative Designs - Collignon

Estimand Framework and Its Impact on Drug Development in ...

Towards a better use of scientific advice for developers of advanced ...bpspubs.onlinelibrary.wiley.com › doi › abs › bcp

[PDF] enhancing-patient-centric-outcome-measures-and-clinical-trials-with ...www.efpia.eu › media › enhancing-patient-centric-outcome-measures...

Meeting Minutescioms.ch › wp-content › uploads ›

Meeting Minutes

[PDF] Meeting Minutescioms.ch › wp-content › uploads ›

Twitter-Nachrichten: Elizabeth Merrall on X: "Anja Schiel from the Norwegian Medicines ...twitter.com › ElmStatistics › status

Twitter-Nachrichten: The Evidence Base on X: "Day 2 of #ISPOREurope is underway ...twitter.com › TheEviBase › status

Anja E. Schiel, PhD, Senior Advisor - RAPS Convergence 2022eventscribe.net

Advisory Group | ROADMAPROADMAP Alzheimer

Agenda Day 2 | International Conference on Rare Diseases

Governance - Aladdinaladdin-education.eu › governance

Schielradgestalten.de

Making Real World Data Real – New RWE Methodologies for HTAsvitaltransformation.com › › making-real-world-data-real-new-rwe...

PSI Conference | May Updatepsi.glueup.com › organization › campaign

PLOS ONE: Antigenic Differences between AS03 Adjuvanted Influenza A...

Preconference Workshop: Drug Development in EU: Regulatory ...www.eventscribe.net › RAPSConvergence2022

Archives | Biostatistics and statistical programming - Staburostaburo.com ›

The New Pharma Legislation Proposal: The Good, the Bad or the www.ispor.org › program › session › euro

Speakers | TOPRA Annual Symposium 2022

Technologies in Medicine Development

Drug Development in EU - RAPS Convergence 2022

Alle Infos zum Namen "Anja Schiel"